← Leaderboards
Andrew Caleb Hsieh
Fred Hutchinson Cancer Center
$6,779,569
Attributed
$7,835,569
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,835,569 · 4
By mechanism
R01$3,809,731 · 2
R37$3,135,550 · 1
K08$890,288 · 1
Top collaborators
- Slobodan Beronja5 shared
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- Peter S Nelson$31,175,698
Others in their field
Top investigators on “Protein Biosynthesis”
- Kent J. Weinhold · Duke University$39,902,311
- Myron Fredric Goodman · University Of Southern California$21,511,591
- Craig A Townsend · Johns Hopkins University$20,563,122
- Bruce W Stillman · Cold Spring Harbor Laboratory$20,241,203
- Dieter G Soll · Yale University$20,125,460
- K. Sreekumaran Nair · University Of Vermont &St Agric College$19,973,818
Research focus
Protein BiosynthesisGenesMolecularMouse ModelMediatingMalignant NeoplasmsLaboratoriesMessenger RnaTranslationsProgramsIn VivoTranslation InitiationTissuesGeneticLinkPeptide Initiation FactorsPhenotypeRibosome ProfilingOncogenicRegulatory ElementAndrogensProteinsMalignant Neoplasm Of ProstateGenetic Translation
Grant awards (23)
Transcriptional-translational conflict in bladder epithelial homeostasis and cancer$569,061
R01 · FY2025 · CA · contact PI
Hormone signaling and translation control in advanced prostate cancer$433,940
R37 · FY2025 · CA · contact PI
Transcriptional-translational conflict in bladder epithelial homeostasis and cancer$540,609
R01 · FY2024 · CA · contact PI
Hormone signaling and translation control in advanced prostate cancer$412,243
R37 · FY2024 · CA · contact PI
Transcriptional-translational conflict in bladder epithelial homeostasis and cancer$588,061
R01 · FY2023 · CA · contact PI
Selective mRNA translation in developmental disorders$528,000
R01 · FY2023 · GM
Hormone signaling and translation control in advanced prostate cancer$425,261
R37 · FY2023 · CA · contact PI
Selective mRNA translation in developmental disorders$528,000
R01 · FY2022 · GM
Hormone signaling and translation control in advanced prostate cancer$271,335
R37 · FY2022 · CA · contact PI
Hormone signaling and translation control in advanced prostate cancer$164,031
R37 · FY2022 · CA · contact PI
Selective mRNA translation in developmental disorders$433,184
R01 · FY2021 · GM
Hormone signaling and translation control in advanced prostate cancer$420,691
R37 · FY2021 · CA · contact PI
Selective mRNA translation in developmental disorders$94,816
R01 · FY2021 · GM
Selective mRNA translation in developmental disorders$528,000
R01 · FY2020 · GM
Hormone signaling and translation control in advanced prostate cancer$420,691
R37 · FY2020 · CA · contact PI
Hormone signaling and translation control in advanced prostate cancer$166,667
R37 · FY2020 · CA · contact PI
Hormone signaling and translation control in advanced prostate cancer$420,691
R37 · FY2019 · CA · contact PI
Defining the role of eIF4F in metastatic castration resistant prostate cancer$169,560
K08 · FY2017 · CA · contact PI
Defining the role of eIF4F in metastatic castration resistant prostate cancer$169,560
K08 · FY2016 · CA · contact PI
Defining the role of eIF4F in metastatic castration resistant prostate cancer$169,560
K08 · FY2015 · CA · contact PI
Defining the role of eIF4F in metastatic castration resistant prostate cancer$111,744
K08 · FY2014 · CA · contact PI
Defining the role of eIF4F in metastatic castration resistant prostate cancer$79,060
K08 · FY2014 · CA · contact PI
Defining the role of eIF4F in metastatic castration resistant prostate cancer$190,804
K08 · FY2013 · CA · contact PI